Reports Q4 revenue $2B, consensus $1.96B. “Solventum’s (SOLV) fourth quarter results reflect another quarter of solid performance resulting in full year 2025 results ahead of our expectations for sales and EPS,” said CEO Bryan Hanson. “We continue to deliver on our commitments; our underlying momentum and the intentional steps we’ve taken in our transformation journey demonstrate clear progress towards achieving our long-range plan.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Trian boosts stakes in GE Aerospace and GE Healthcare, cuts Invesco stake
- Balanced View on Solventum: Differentiated Healthcare IT AI Offsets Early-Stage Turnaround Risk, Supporting a Hold Rating
- Solventum upgraded to Overweight from Sector Weight at KeyBanc
- Solventum upgraded to Outperform from Neutral at Mizuho
- Solventum price target raised to $105 from $88 at Stifel